ASCO Guidelines
Podcast tekijän mukaan American Society of Clinical Oncology (ASCO)
175 Jaksot
-
Considerations for the Use of Steroids: Management of irAEs Guideline (Part 13)
Julkaistiin: 16.11.2021 -
Ocular Toxicities: Management of irAEs Guideline (Part 12)
Julkaistiin: 15.11.2021 -
Cardiovascular Toxicities: Management of irAEs Guideline (Part 11)
Julkaistiin: 12.11.2021 -
Hematologic Toxicities: Management of irAEs Guideline (Part 10)
Julkaistiin: 11.11.2021 -
Nervous System Toxicities: Management of irAEs Guideline (Part 9)
Julkaistiin: 10.11.2021 -
Renal Toxicities: Management of irAEs Guideline (Part 8)
Julkaistiin: 9.11.2021 -
Musculoskeletal Toxicities: Management of irAEs Guideline (Part 7)
Julkaistiin: 8.11.2021 -
Endocrine Toxicities: Management of irAEs Guideline (Part 6)
Julkaistiin: 5.11.2021 -
Lung Toxicities: Management of irAEs Guideline (Part 5)
Julkaistiin: 4.11.2021 -
Gastrointestinal Toxicities: Management of irAEs Guideline (Part 4)
Julkaistiin: 3.11.2021 -
Cutaneous Toxicities: Management of irAEs Guideline (Part 3)
Julkaistiin: 2.11.2021 -
CAR-T Cell Therapy: Management of irAEs Guideline (Part 2)
Julkaistiin: 1.11.2021 -
ICPi Overview: Management of irAEs Guideline (Part 1)
Julkaistiin: 1.11.2021 -
Immunotherapy in Patients with Locally Advanced Esophageal Carcinoma: ASCO Guideline Rapid Recommendation Update
Julkaistiin: 18.8.2021 -
Adjuvant PARP Inhibitors in Patients with High-risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update
Julkaistiin: 3.8.2021 -
Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative Guidelin
Julkaistiin: 29.7.2021 -
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Guideline Update
Julkaistiin: 29.7.2021 -
Telehealth in Oncology: Standards and Practice Recommendations
Julkaistiin: 28.7.2021 -
Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline
Julkaistiin: 20.7.2021 -
Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline
Julkaistiin: 19.7.2021
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
